| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.61B | 38.76B | 41.51B | 40.84B | 49.53B | 32.85B |
| Gross Profit | 12.42B | 9.02B | 10.90B | 11.77B | 16.26B | 10.58B |
| EBITDA | 17.78B | 17.99B | 15.41B | 17.27B | 21.73B | 16.38B |
| Net Income | 9.71B | 10.82B | 6.11B | 8.23B | 10.94B | 7.66B |
Balance Sheet | ||||||
| Total Assets | 94.05B | 91.83B | 85.36B | 75.95B | 76.14B | 76.67B |
| Cash, Cash Equivalents and Short-Term Investments | 808.00M | 673.00M | 131.00M | 1.40B | 1.41B | 1.05B |
| Total Debt | 20.02B | 19.72B | 20.28B | 12.35B | 12.98B | 16.28B |
| Total Liabilities | 49.41B | 47.46B | 45.89B | 36.12B | 37.97B | 39.72B |
| Stockholders Equity | 44.64B | 44.37B | 39.47B | 39.83B | 38.17B | 36.95B |
Cash Flow | ||||||
| Free Cash Flow | 6.52B | 8.43B | 8.00B | 7.44B | 14.29B | 9.99B |
| Operating Cash Flow | 14.10B | 15.11B | 13.39B | 12.35B | 19.39B | 14.48B |
| Investing Cash Flow | -7.32B | -6.69B | -14.10B | -4.86B | -4.99B | -3.70B |
| Financing Cash Flow | -6.11B | -7.88B | -37.00M | -7.54B | -14.23B | -10.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | C$20.32B | 213.66 | 7.70% | 6.33% | 80.64% | -50.20% | |
75 Outperform | C$25.99B | 9.80 | 4.40% | 4.79% | 7.06% | -45.27% | |
73 Outperform | C$8.06B | 33.57 | 7.89% | 3.76% | -6.33% | -8.64% | |
73 Outperform | C$17.60B | 7.04 | 17.43% | 2.95% | 17.91% | 11.40% | |
70 Outperform | C$137.84B | 26.23 | 22.74% | 5.23% | 0.74% | 29.91% | |
70 Outperform | C$10.46B | 57.81 | 13.89% | 2.99% | -24.78% | 5.03% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% |